[1]
|
C. Davenport, A. Liew, B. Doherty, et al., “The Prevalence of Adrenal Incidentaloma in Routine Clinical Practice,” Endocrine, Vol. 40, No. 1, 2011, pp. 80-83.
doi:10.1007/s12020-011-9445-6
|
[2]
|
S. Bovio, A. Cataldi, G. Reimondo, et al., “Prevalence of Adrenal Incidentaloma in a Contemporary Computerized Tomography Series,” Journal of Endocrinological Investigation, Vol. 29, No. 4, 2006, pp. 298-302.
|
[3]
|
M. Terzolo, A. Stigliano, I. Chiodini, et al., “Italian Association of Clinical Endocrinologists. AME Position Statement on Adrenal Incidentaloma,” European Journal of Endocrinology, Vol. 164, No. 6, 2011, pp. 851-870.
doi:10.1530/EJE-10-1147
|
[4]
|
G. W. Boland, M. A. Blake, P. F. Hahn and W. W. Mayo-Smith, “Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization,” Radiology, Vol. 249, No. 3, 2008, pp. 756-775.
doi:10.1148/radiol.2493070976
|
[5]
|
E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein and M. E. Baker, “Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis,” American Journal of Roentgenology, Vol. 174, 2000, pp. 1033-1039.
|
[6]
|
F. E. Nwariaku, J. Champine, L. T. Kim, S. Burkey, G. O’keefe and W. H. Snyder III, “Radiologic Characterization of Adrenal Masses: The Role of Computed Tomography—Derived Attenuation Values,” Surgery, Vol. 130, No. 6, 2001, pp. 1068-1071.
doi:10.1067/msy.2001.119189
|
[7]
|
A. H. Hamrahian, A. G. Ioachimescu, E. M. Remer, et al., “Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience,” Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 2, 2005, pp. 871-877. doi:10.1210/jc.2004-1627
|
[8]
|
G. W. Boland, M. J. Lee, G. S. Gazelle, E. F. Halpern, M. M. McNicholas and P. R. Mueller, “Characterization of Adrenal Masses Using Unenhanced CT: An Analysis of the CT Literature,” American Journal of Roentgenology, Vol. 171, No. 1, 1998, pp. 201-204.
|
[9]
|
S. H. Park, M. J. Kim, J. H. Kim, J. S. Lim and K. W. Kim, “Differentiation of Adrenal Adenoma and Nonadenoma in Unenhanced CT: New Optimal Threshold Value and the Usefulness of Size Criteria for Differentiation,” Korean Journal of Radiology, Vol. 8, No. 4, 2007, pp. 328-335. doi:10.3348/kjr.2007.8.4.328
|
[10]
|
M. A. Eloubeidi, K. R. Black, A. Tamhane, I. A. Eltoum, A. Bryant and R. J. Cerfolio, “A Large Single-Center Experience of EUS-Guided FNA of the Left and Right Adrenal Glands: Diagnostic Utility and Impact on Patient Management,” Gastrointestinal Endoscopy, Vol. 71, No. 4, 2010, pp. 745-753. doi:10.1016/j.gie.2009.10.022
|
[11]
|
Y. M. Sung, K. S. Lee, B. T. Kim, et al., “(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: A Comparison of Diagnostic Efficacy in Lung Cancer Patients,” Korean Journal of Radiology, Vol. 9, No. 1, 2008, pp. 19-28.
doi:10.3348/kjr.2008.9.1.19
|
[12]
|
U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital and E. Even-Sapir, “18F-FDG PET/CT in the Evaluation of Adrenal Masses,” Journal of Nuclear Medicine, Vol. 47, No. 1, 2006, pp. 32-37.
|
[13]
|
M. Nakajo, M. Nakajo, Y. Kajiya, et al., “A Black Adrenal Adenoma Difficult to be Differentiated from a Malignant Adrenal Tumor by CT, MRI, Scintigraphy and FDG PET/CT Examinations,” Annals of Nuclear Medicine, Vol. 25, No. 10, 2011, pp. 812-817.
doi:10.1007/s12149-011-0535-6
|
[14]
|
S. Chong, K. S. Lee, H. Y. Kim, et al., “Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls,” Radiographics, Vol. 26, No. 6, 2006, pp. 1811-1824. doi:10.1148/rg.266065057
|
[15]
|
M. Okada, T. Shimono, Y. Komeya, et al., “Adrenal masses: The Value of Additional Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Differentiating between Benign and Malignant Lesions,” Annals of Nuclear Medicine, Vol. 23, No. 4, 2009, pp. 349-354.
doi:10.1007/s12149-009-0246-4
|
[16]
|
B. Xu, J. Gao, L. Cui, et al., “Characterization of Adrenal Metastatic Cancer Using FDG PET/CT,” Neoplasma, Vol. 59, No. 1, 2012, pp. 92-99. doi:10.4149/neo_2012_012
|
[17]
|
M. Perri, P. Erba, D. Volterrani, et al., “Adrenal Masses in Patients with Cancer: PET/CT Characterization with Combined CT Histogram and Standardized Uptake Value PET Analysis,” American Journal of Roentgenology, Vol. 197, No. 1, 2011, pp. 209-216. doi:10.2214/AJR.10.5342
|
[18]
|
N. C. Nguyen, A. Kaushik, M. K. Wolverson and M. M. Osman, “Is There a Common SUV Threshold in Oncological FDG PET/CT, at Least for Some Common Indications? A Retrospective Study,” Acta Oncologica, Vol. 50, No. 5, 2011, pp. 670-677.
doi:10.3109/0284186X.2010.550933
|
[19]
|
M. J. Brady, J. Thomas, T. Z. Wong, K. M. Franklin, L. M. Ho and E. K. Paulson, “Adrenal Nodules at FDG PET/CT in Patients Known to Have or Suspected of Having Lung Cancer: A Proposal for an Efficient Diagnostic Algorithm,” Radiology, Vol. 250, No. 2, 2009, pp. 523-530. doi:10.1148/radiol.2502080219
|
[20]
|
S. Jana, T. Zhang, D. M. Milstein, C. R. Isasi and M. D. Blaufox, “FDG-PET and CT Characterization of Adrenal Lesions in Cancer Patients,” European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, No. 1, 2006, pp. 29-35. doi:10.1007/s00259-005-1915-8
|
[21]
|
C. Ansquer, S. Scigliano, E. Mirallié, et al., “18F-FDG PET/CT in the Characterization and Surgical Decision Concerning Adrenal Masses: A Prospective Multicentre Evaluation,” European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, No. 9, 2010, pp. 1669-1678.
doi:10.1007/s00259-010-1471-8
|
[22]
|
I. Kayani, N. Avril, J. Bomanji, et al., “Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer,” Clinical Cancer Research, Vol. 17, No. 18, 2011, pp. 6021-6028.
doi:10.1158/1078-0432.CCR-10-3309
|
[23]
|
M. Okada, T. Shimono, Y. Komeya, et al., “Adrenal Masses: The Value of Additional Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Differentiating between Benign and Malignant Lesions,” Annals of Nuclear Medicine, Vol. 23, No. 4, 2009, pp. 349-354.
doi:10.1007/s12149-009-0246-4
|
[24]
|
P. S. Duarte, H. Zhuang, P. Castellucci and A. Alavi, “The Receiver Operating Characteristic Curve for the Standard Uptake Value in a Group of Patients with Bone Marrow Metastasis,” Molecular Imaging and Biology, Vol. 4, No. 2, 2002, pp. 157-160.
doi:10.1016/S1095-0397(01)00060-7
|
[25]
|
R. Hong, J. Halama, D. Bova, A. Sethi and B. Emami, “Correlation of PET Standard Uptake Value and CT Window-Level Thresholds for Target Delineation in CT-Based Radiation Treatment Planning,” International Journal of Radiation Oncology*Biology*Physics, Vol. 67, No. 3, 2007, pp. 720-726.
|
[26]
|
D. Wang, C. J. Schultz, P. A. Jursinic, et al., “Initial Experience of FDG-PET/CT Guided IMRT of Head-and-Neck Carcinoma,” International Journal of Radiation Oncology*Biology*Physics, Vol. 65, No. 1, 2006, pp. 143-151.
|
[27]
|
T. L. Ang, T. S. Chua, K. M. Fock, A. K. Tee, E. K. Teo and K. Mancer, “EUS-FNA of the Left Adrenal Gland Is Safe and Useful,” Annals Academy of Medicine Singapore, Vol. 36, No. 11, 2007, pp. 954-957.
|
[28]
|
U. Bodtger, P. Vilmann, P. Clementsen, E. Galvis, K. Bach and B. G. Skov, “Clinical Impact of Endoscopic Ultrasound-Fine Needle Aspiration of Left Adrenal Masses in Established or Suspected Lung Cancer,” Journal of Thoracic Oncology, Vol. 4, No. 12, 2009, pp. 1485-1489.
doi:10.1097/JTO.0b013e3181b9e848
|
[29]
|
J. DeWitt, M. Alsatie, J. LeBlanc, L. McHenry and S. Sherman, “Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Left Adrenal Gland Masses,” Endoscopy, Vol. 39, No. 1, 2007, pp. 65-71.
doi:10.1055/s-2006-945042
|
[30]
|
M. A. Eloubeidi, S. Seewald, A. Tamhane, et al., “EUS-Guided FNA of the Left Adrenal Gland in Patients with Thoracic or GI Malignancies,” Gastrointestinal Endoscopy, Vol. 59, No. 6, 2004, pp. 627-633.
doi:10.1016/S0016-5107(04)00296-2
|
[31]
|
M. A. Eloubeidi, L. P. Luz, D. R. Crowe, C. Snowden, D. E. Morgan and P. J. Arnoletti, “Bilateral Adrenal Gland Enlargement Secondary to Histoplasmosis Mimicking Adrenal Metastases: Diagnosis with EUS-Guided FNA,” Diagnostic Cytopathology, Vol. 38, No. 5, 2010, pp. 357-359.
|
[32]
|
N. C. Jhala, D. Jhala, M. A. Eloubeidi, et al., “Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy of the Adrenal Glands: Analysis of 24 Patients,” Cancer, Vol. 102, No. 5, 2004, pp. 308-314.
doi:10.1002/cncr.20498
|
[33]
|
O. C. Schuurbiers, K. G. Tournoy, H. J. Schoppers, et al., “EUS-FNA for the Detection of Left Adrenal Metastasis in Patients with Lung Cancer,” Lung Cancer, Vol. 73, No. 3, 2011, pp. 310-315. doi:10.1016/j.lungcan.2010.12.019
|
[34]
|
H. Gerke, R. A. Robinson and P. Luo, “Diagnosis of Focal Metastasis to the Adrenal Gland by EUS-Guided Core Biopsy,” Gastrointestinal Endoscopy, Vol. 62, No. 3, 2005, pp. 469-471. doi:10.1016/S0016-5107(05)01578-6
|
[35]
|
E. B. Stelow, S. M. Debol, M. W. Stanley, S. Mallery, R. Lai and R. H. Bardales, “Sampling of the Adrenal Glands by Endoscopic Ultrasound-Guided Fine-Needle Aspiration,” Diagnostic Cytopathology, Vol. 33, No. 1, 2005, pp. 26-30. doi:10.1002/dc.20273
|
[36]
|
E. L. Artifon, A. M. Lucon, P. Sakai, et al., “EUS-Guided Alcohol Ablation of Left Adrenal Metastasis from Non-Small-Cell Lung Carcinoma,” Gastrointestinal Endoscopy, Vol. 66, No. 6, 2007, pp. 1201-1205.
doi:10.1016/j.gie.2007.05.051
|
[37]
|
J. T. Lenert, C. C. Barnett Jr., A. P. Kudelka, et al., “Evaluation and Surgical Resection of Adrenal Masses in Patients with a History of Extra-Adrenal Malignancy,” Surgery, Vol. 130, No. 6, 2001, pp. 1060-1067.
doi:10.1067/msy.2001.118369
|
[38]
|
L. Hammarstedt, A. Muth, H. A. Sigurjónsdóttir, E. Almqvist, B. W?ngberg and M. Hellstr?m, “On Behalf of the Adrenal Study Group of Western Sweden. Adrenal Lesions in Patients with Extra-Adrenal Malignancy— Benign or Malignant?” Acta Oncologica, Vol. 51, No. 2, 2012, pp. 215-221. doi:10.3109/0284186X.2011.608084
|
[39]
|
L. Yip, M. E. Tublin, J. A. Falcone, et al., “The Adrenal Mass: Correlation of Histopathology with Imaging,” Annals of Surgical Oncology, Vol. 17, No. 3, 2010, pp. 846-852. doi:10.1245/s10434-009-0829-2
|
[40]
|
J. M. Meier, A. Alavi, S. Iruvuri, et al., “Assessment of Age-Related Changes in Abdominal Organ Structure and Function with Computed Tomography and Positron Emission Tomography,” Seminars in Nuclear Medicine, Vol. 37, No. 3, 2007, pp. 154-172.
doi:10.1053/j.semnuclmed.2007.02.001
|
[41]
|
D. Hellwig, T. P. Graeter, D. Ukena, et al., “18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?” Journal of Nuclear Medicine, Vol. 48, No. 11, 2007, pp. 1761-1766.
doi:10.2967/jnumed.107.044362
|
[42]
|
A. S. Bryant, R. J. Cerfolio, K. M. Klemm and B. Ojha, “Maximum Standard Uptake Value of Mediastinal Lymph Nodes on Integrated FDG-PET-CT predicts Pathology in Patients with Non-Small Cell Lung Cancer,” Annals of Thoracic Surgery, Vol. 82, 2006, pp. 417-422.
doi:10.1016/j.athoracsur.2005.12.047
|
[43]
|
K. J. Chang, R. A. Erickson and P. Nguyen, “Endoscopic Ultrasound (EUS) and EUS-Guided Fine-Needle Aspiration of the Left Adrenal Gland,” Gastrointestinal Endoscopy, Vol. 44, No. 5, 1996, pp. 568-572.
doi:10.1016/S0016-5107(96)70010-X
|
[44]
|
J. M. Dumonceau, M. Polkowski, A. Larghi, et al., “Indications, Results, and Clinical Impact of Endoscopic Ultrasound (EUS)-Guided Sampling in Gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline,” Endoscopy, Vol. 43, No. 10, 2011, pp. 897-912. doi:10.1055/s-0030-1256754
|
[45]
|
C. J. Tyng, A. G. Bitencourt, E. B. Martins, P. N. Pinto and R. Chojniak, “Technical Note: CT-Guided Paravertebral Adrenal Biopsy Using Hydrodissection—A Safe and Technically Easy Approach,” British Journal of Radiology, 2011.
|